Organisation paid for research Program year 2025 Source: CMS Open Payments

Vanguard Research Group

Neither a doctor nor a teaching hospital

Research payments

$1,751,410

44 payments

Through program year 2025, Vanguard Research Group is reported as receiving $1,751,410 in research payments, across 44 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$215,040	1
2022	Research	$543,225	6
2021	Research	$269,944	7
2020	Research	$457,002	20
2019	Research	$266,199	10

Breakdown

Who paid Research payments · program years 2019–2025

Alkermes, Inc. $1,751,410 44 payments

Studies the money was for Research payments · program years 2019–2025

A Study to Evaluate the Effect of ALKS 3831 Compared to OLANZAPINE on Body Weight in Young Adults with Schizophrenia, Schizophreniform, or Bipolar I Disorder Who are Early in Their Illness $1,144,271 21 payments
A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder $315,764 10 payments
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 $291,375 13 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.